Rising antiparasitic drug cost in U.S. leads to higher patient costs, decreased quality of care

Evidence review examines both benefits and harms for lung cancer screening
9 March 2021
Unconscious biases can drive foodborne illness outbreaks, researchers find
9 March 2021

Rising antiparasitic drug cost in U.S. leads to higher patient costs, decreased quality of care

New study finds the skyrocketing cost of drugs in U.S. used to treat hookworm and other soil-transmitted parasites increases patient costs, suggests decreased quality of care

Comments are closed.